Cefapirin Sodium (CAS 24356-60-3) Suppliers and Product Information

Cefapirin sodium is a semisynthetic cephalosporin antibiotic with bactericidal activity against various gram-positive and gram-negative bacteria. It is closely related to cephalothin in chemical and pharmacokinetic properties. Cefapirin sodium is unstable in acid and must be administered parenterally. It is marketed under the trade name Cefadyl and is now primarily used in veterinary practice.

Frequently Asked Questions

Q: Is Cefapirin sodium FDA approved?

A: Yes, Cefapirin sodium is an FDA-approved antimicrobial agent.

Q: What are the main uses of Cefapirin sodium?

A: Cefapirin sodium is used primarily in veterinary practice. It has been used for treating urinary tract infections and osteomyelitis caused by Staphylococcus, Streptococcus, and Escherichia coli. However, it has been discontinued for human use in the United States.

Q: What are the potential side effects of Cefapirin sodium?

A: Some of the most serious adverse reactions to Cefapirin sodium include neutropenia, leukopenia, anemia, bone marrow depression, and allergic reactions.

Q: How does Cefapirin sodium work?

A: Cefapirin sodium works similarly to other cephalosporins. It is bactericidal and interferes with bacterial cell wall synthesis, leading to cell lysis and death of susceptible bacteria.